Harvard Business School (HBS) has named Putnam Alumni Theresa Tribble as one of its 2015-2016 Blavatnik Fellows in Life Science Entrepreneurship. These Fellows, five outstanding HBS alumni who graduated from the School no more than seven years ago, will work with inventors from Harvard University’s research laboratories to promote the commercialization of innovative life science-oriented technologies with significant market potential.
Theresa (MBA 2009) comes to the Blavatnik Fellowship from SynapDx, an autism diagnostics company, where she served most recently as vice president of commercial strategy. As part of the founding team, she was involved in a number of areas, including marketing, communications, clinical collaborations, business development, product planning, and operations. She is on the board of the New England chapter of Autism Speaks. She studied English and political science at Wellesley College. Tribble started her career at Putnam Associates and was a Senior Associate serving an array of clients in oncology, hematology, immunology, primary care, and rare diseases before matriculating to Harvard Business School, a path 13 of her fellow associates have taken in the last 10 years.
The Blavatnik Fellowship Program, which admits five exceptional individuals each year through a competitive application process, was created in 2012 as part of a $50 million gift to Harvard University from the Blavatnik Family Foundation, headed by Len Blavatnik (MBA 1989). The launch of the Fellowship Program was the beginning of a major initiative to expedite new ventures via the Blavatnik Biomedical Accelerator, which identifies and supports early-stage, highly promising technologies from Harvard University. The Fellows work closely with inventors through Harvard’s Office of Technology Development to determine the best route for the commercialization of a product.